Synmosa Biopharma Corporation
TPEX:4114
NT$ 39.10
NT$-0.30 (-0.76%)
NT$ 39.10
NT$-0.30 (-0.76%)
End-of-day quote: 05/09/2024

4114 - Synmosa Biopharma Stock Prediction 2025 - 2030

20 years of reliable Synmosa Biopharma stock forecast. The Wall Street analysts predict Data Unavailable for 4114. See at a glance whether TPEX:4114 will rise in the future.

NT$75.82
Forecast 2023
NT$99.73
Forecast 2025
NT$91.75
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
NT$75.82
Forecast 2025
NT$99.73
Forecast 2030
NT$91.75
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.27
Price-to-book Ratio
2.23
Market Cap
14.73B
TEV
16.20 B
Dividend
NT$0.59
Div Yld
1.52%
Forecast 1Y
140.73%
Forecast 2Y
0.00%
Analyst Price Target
NT$36.00
Country

Synmosa Biopharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Synmosa Biopharma Stock Forecast 2023

NT$0.00

In the last five quarters, Synmosa Biopharma’s Price Target has risen from NT$36.00 to NT$36.00 - a 0% increase. One analysts predict that Synmosa Biopharma’s share price will fall in the coming year, reaching NT$0.00. This would represent a decrease of -100%.

-100%
-100
Last update: 05/10/2024

Highest Price Target NT$0.00

Average Price Target NT$0.00

Lowest Price Target NT$0.00

Synmosa Biopharma Stock Forecast 2025

Stock Prediction for the Price of One Synmosa Biopharma Share in Jan 2025.

In Jan 2025 analysts predict a share price of NT$93.38. An increase of 138.83% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Feb 2025.

In Feb 2025 analysts predict a share price of NT$93.96. An increase of 140.3% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Mar 2025.

In Mar 2025 analysts predict a share price of NT$94.54. An increase of 141.78% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Apr 2025.

In Apr 2025 analysts predict a share price of NT$95.11. An increase of 143.26% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in May 2025.

In May 2025 analysts predict a share price of NT$95.69. An increase of 144.73% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Jun 2025.

In Jun 2025 analysts predict a share price of NT$96.27. An increase of 146.21% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Jul 2025.

In Jul 2025 analysts predict a share price of NT$96.85. An increase of 147.69% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Aug 2025.

In Aug 2025 analysts predict a share price of NT$97.42. An increase of 149.16% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Sep 2025.

In Sep 2025 analysts predict a share price of NT$98.00. An increase of 150.64% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Oct 2025.

In Oct 2025 analysts predict a share price of NT$98.58. An increase of 152.12% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Nov 2025.

In Nov 2025 analysts predict a share price of NT$99.16. An increase of 153.59% compared to today's share price.

Stock Prediction for the Price of One Synmosa Biopharma Share in Dec 2025.

In Dec 2025 analysts predict a share price of NT$99.73. An increase of 155.07% compared to today's share price.

Synmosa Biopharma Stock Predictions 2030

Synmosa Biopharma Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of NT$84.75. An increase of 116.75% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of NT$85.39. An increase of 118.38% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of NT$86.02. An increase of 120.01% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of NT$86.66. An increase of 121.64% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of NT$87.30. An increase of 123.26% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of NT$87.93. An increase of 124.89% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of NT$88.57. An increase of 126.52% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of NT$89.21. An increase of 128.15% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of NT$89.84. An increase of 129.78% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of NT$90.48. An increase of 131.41% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of NT$91.12. An increase of 133.03% compared to the previous month's estimate.

Synmosa Biopharma Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of NT$91.75. An increase of 134.66% compared to the previous month's estimate.

P/E
0.00
Beta
0.27
Price-to-book Ratio
2.23
Market Cap
14.73B
TEV
16.20 B
Dividend
NT$0.59
Div Yld
1.52%
Forecast 1Y
140.73%
Forecast 2Y
0.00%
Analyst Price Target
NT$36.00
Country

Synmosa Biopharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Synmosa Biopharma Corporation?

The following analysts have recently covered Synmosa Biopharma:

Data Unavailable
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Synmosa Biopharma Corporation?

The following sell-side analysts have recently covered Synmosa Biopharma:

Data Unavailable
(This information refers to the last 90 days.)